이상의 실험결과들을 요약하면, CFA를 안면영역 피하로 주입하여 발생한 염증성 통증 행위반응은 P2X 수용체의 억제제의 투여로 감소할 수 있었다. 특히 P2X7 수용체 억제제를 투여하면 진통작용 뿐 아니라 활성화된 신경아교세포 발현을 억제하였다. 이러한 실험 결과는 P2X7 수용체가 신경아교세포에 영향을 미쳐 안면에서 발생하는 만성 염증성 통증의 발생과 유지에 관여하고 있다는 것을 보여준다. 따라서 중추신경계의 신경아교세포를 조절할 수 있는 중추성 P2X7 수용체 작용기전은 임상에서 만성 염증성 통증을 보다 효과적으로 치료할 수 있는 새로운 방법을 제시해 줄 수 있다고 생각된다.

까le orofacial pain is one of the most common types of acute or chronic pain, and many forms of orofacial pain have an inflammatory component. The aim of this study was to develop a behavioral model of orofacial pain associated with chronic int1ammation in rats. 까le int1ammatory agent, CFA suspended in an oil/saline (1 :1) emulsion (50 씨) was injected into the vibrissal pad of adult male rats. A s따피ar application of saline was served as control. Spontaneous and mechanically evoked behaviours were monitored daily in awake rats before and up to 6 weeks after injection. As for the spontaneous behaviour, total time rat spent in face gr∞ming was counted. For the measurement of mechanically evoked behaviour, the threshold and frequency of head withdrawal response (HWR) were determined at the vibrissal pad with the use of von Frey nylon monofilaments. CFA injection did not produce any significant changes in face gr∞ming， but produced a s핑nificant reduction in HWR threshold and a s핑nificant increase in HWR frequency to mechanical stimulation of the vibrissal pad on the ipsilateral side for approximately 4-6 weeks. Saline injection into the vibrissal pad did not produce any significant changes in spontaneous and mechanically evoked behaviours. These results indicate that the injection of CFA into orofacial cutaneous tissues can induce persistent behavioral allodynia and hyperalgesia, and easily quantified behavioral model will provide a better understanding of mechanisms and control of orofacial chronic pain conditions associated with int1ammation.